DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)
5,020.00
-70.00 (-1.38%)
At close: Aug 7, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2014 - 2019 |
Medicine | 247.53B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medicine Growth | 15.20% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Marketing Agency | 3.35B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Marketing Agency Growth | 41.98% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Finance | 2.14B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Finance Growth | 121.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidation Adjustment | -3.74B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidation Adjustment Growth | 48.77% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Product | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Product Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Merchandise | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Merchandise Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2014 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2014 - 2019 |
South Korea | 249.27B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea Growth | 15.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Overseas | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Overseas Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|